Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 5 , Pages 723-735, October 2008

Human genetics of osteoporosis

  • Serge Ferrari, MD (Associate Professor of Medicine and Osteoporosis genetics)

      Affiliations

    • Corresponding Author InformationTel.: +4122 372 99 50; Fax: +4122 382 99 73.

Service of Bone Diseases, Department of Rehabilitation and Geriatrics, WHO Collaborating Center for Osteoporosis Prevention, Geneva University Hospital and Faculty of Medicine, 24, rue Micheli-du-Crest, CH – 1211 Genève 14, Switzerland

A family history of hip fracture carries a twofold increased risk of fracture among descendants. Genetic factors indeed play a major role in the determination of bone mineral density (BMD) and osteoporosis risk. Multiple chromosomal loci have been mapped by linkage approaches which potentially carry hundreds of genes involved in the determination of bone mass and quality. Association studies based on candidate gene polymorphisms and subsequent meta-analyses, and the more recent genome-wide association studies (GWAS), have clearly identified a handful of genes associated with BMD and/or fragility fractures. Among them are genes coding for the LDL-receptor related protein 5 (LRP5), estrogen receptor alpha (ESR1) and osteoprotegerin, OPG (TNFRSf11b). However, the percentage of osteoporosis risk explained by any of these polymorphisms is small, indicating that most genetic risk factors remain to be discovered and/or that interaction with environmental factors needs further consideration.

Key words: bone, osteoporosis, gene, polymorphism, fracture, LRP5, interleukin-6, estrogen receptor, vitamin D receptor, osteoprotegerin, QTL, GWAS

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(08)00093-6

doi:10.1016/j.beem.2008.08.007

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 5 , Pages 723-735, October 2008